000 01507 a2200457 4500
005 20250517033830.0
264 0 _c20160927
008 201609s 0 0 eng d
022 _a1477-0970
024 7 _a10.1177/1352458515586086
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacMillan, E L
245 0 0 _aProgressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_cJan 2016
300 _a112-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGlutamic Acid
_xmetabolism
650 0 4 _aGlutamine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis, Chronic Progressive
_xmetabolism
650 0 4 _aTime Factors
700 1 _aTam, R
700 1 _aZhao, Y
700 1 _aVavasour, I M
700 1 _aLi, D K B
700 1 _aOger, J
700 1 _aFreedman, M S
700 1 _aKolind, S H
700 1 _aTraboulsee, A L
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 22
_gno. 1
_gp. 112-6
856 4 0 _uhttps://doi.org/10.1177/1352458515586086
_zAvailable from publisher's website
999 _c24937444
_d24937444